Clinical Trials Browser

Phase 2 × Breast Neoplasms × Immunotherapy × Clear all

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT07254858 2025-11-28

CISN-L

Phase 2 Not yet recruiting

Breast Neoplasms